Financials

  • Market Capitalization 306.99 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.51
Rapporto prezzo/fatturato
8.81

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3265
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.29 USD-2.76%-0.94%+4.13%-4.34%319.85 M USD
3294
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.19 USD+1.57%-2.99%+35.51%+92.22%311.95 M USD
3341
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.85 USD0.00%+0.26%+7.54%-39.84%293.74 M USD
3344
TTRX
Turn Therapeutics Inc. - Common Stock
9.84 USD-2.67%+4.79%+31.55%-1.60%293.11 M USD